Introduction
Rheumatoid arthritis (RA) is a systemic connective tissue autoimmune disease which is characterized by inflammation of synovial joints which can lead to cartilage destruction as well as bone erosion (1) .Although its etiology is unknown, the interactions between both genetic and environmental factors have been demonstrated in RA (2) . Vitamin D has a broad range of biological effects that ranges fromits classical role as a mediator of phosphorus and calcium metabolism which promotes the healthy mineralization, growth and remodeling of the bone, to the modulation of cellular differentiation and anti-microbial activity (3) .
Vitamin D and its analogues suppress T-cell proliferation as well as they inhibit the expression of proinflammatory cytokines involved in the pathogenesis of RAwhich include interleukin (IL)-2 and interferon-γ(4).
Epidemiological studies concerned with the relationship between serum 25(OH)D concentrations and RA have conflicting results (1, 5) . Several studies demonstrated a reverse relationship between serum 25(OH)D concentrations and activity of RA, however, studies contradictory to these observations are also found (6-13). Because of these contradictory results regarding the effect of serum 25(OH)D concentrations on the severity of RA, the present study performedto estimatethe serum 25(OH)D concentrations and their relationship with parameters of disease activity in patients with RA living in upper Egypt. The definition of vitamin D deficiency,vitamin D insufficiency and normal vitamin Dlevels are defined as the serum 25(OH)D concentration≤ 20 ng/ml, between 20-30 ng/ml and ≥ 30 ng/ml,respectively. All patients with RA in this study were treated by methotrexate (15 mg/week) and leflunomide (20 mg/day). Nonsteroidal anti-inflammatory drugs were prescribed only on demand for pain.
Patients and methods

Statistical analysis.
Statistical package for social sciences (IBM-SPSS), version 24 IBMChicago, USA (May 2016) was used for statistical data analysis. Data expressed as mean, standard deviation (SD), number and percentage. Mean and standard deviation were used as descriptive value for quantitative data, while number and percentage were used to describe qualitative data. Student t test was used to compare the means between two groups, and Pearson correlation test was used to compare two quantitative variables.
The level of significance was considered when the p value is < 0.05.
Results
This study included 34 female RA patients from upper Egypt with a mean age of 34.21±6.06 (range; 22-45) years and 34 female controls with a mean age of 34.63±7.38 (range; 24-44) years. The demographic and clinical characteristics of patients with RA and of control subjects are shown in Table 1 . Age did not show statistically significant difference between RA patients and control subjects (P = 0.814). Patients with RA had mild to moderate (DAS28 < 5.1) disease activity. The mean serum 25(OH) D in patients with RA (24.35±5.66 ng/ml) was significantly lower (p< 0.001) than controls (42.46±11.33 ng/ml) ( Table 1 and Fig. 1 ). Serum 25(OH)D concentrations did not show significant correlation with age, disease duration, ESR, CRP, VAS, or DAS28 in patients with RA ( Table 2 ). Serum 25(OH)D levels had no relation to rheumatoid factor or anti CCP (Table 3) . In the present study, we showed that the serum 25(OH)D concentrations were significantly lower in the RA group compared to the control group (P < 0.001). These results are in agreement with other studies (9, 19-21).In contrast to these results, other studies reported that the levels of serum 25(OH)Din RA patients were not different from that of controls In the present study, serum 25(OH)D concentrationswere not correlated with disease duration which was in agreement with other study (27) . In the current study age was significantly correlated with serum 25(OH)D levelswhich was in contrast to other study (27) .In our study, Serum 25(OH)D levels had no relation to RF or anti-CCP positivity.
Many limitations are present to the current study that may lead to the contradictory results between this study and other previous ones. Of these are, the small sample size, absence of RA patients with deficient serum 25(OH)D levels and lack of information about sun exposure time. Further studies are required to yield more information about the effects of vitamin D in patients with RA.
In conclusion,Serum25(OH)D levels are lower in RA patients compared to controls. There are no association between Serum25(OH)D levels and disease activity in patients with RA living in upper Egypt. 
